https://pictilisibinhibitor.co....m/extended-noncoding
Results The prognostic cut-off values had been determined as -2.18, and -0.23 (P less then 0.001). Patients had 5-year cancer-specific success rates of 83.8%, 57.4% and 24.4% with increasing LODDS (P less then 0.001) into the SEER database. Five-year general survival rates were 77.2%, 55.0% and 26.7% with increasing LODDS (P less then 0.001) in the additional intercontinental multicenter cohort. Multivariate survival analysis identified both the LODDS classification, the in-patient's a
Like
Comment
Share
